We believe in innovation through research. BITS research enterprise encourages collaborations that make innovations and research advances possible. By bridging basic and applied research, we’re helping create new areas of research and building the foundations for industries of the future.
Self assembling pH-sensitive temozolomide-lipoic acid conjugate nanomedicine for treatment of glioblastoma multiforme
Rod-shaped polymeric nanoparticles for targeted delivery of artemisinin-derivatives to plasmodium-infected erythrocytes for improved intravenous therapy of cerebral malaria
Design and evaluation of a lowcost lab-on-chip noninvasive device for diagnosis of Psoriasis skin disorder: investigation of skin elasticity in psoriatic disease condition and correlation with treatment efficacy of designed nanoformulations
APREMILAST LOADED HALLOYSITE NANOTUBES COMPOSITE ENCAPSULATED IN ELECTROSPUN NANOPATCHES A NOVEL TREATMENT FOR PSORIASIS
Design, Synthesis, Biological Evaluation and Molecular modelling studies of Indolyl Oxoacetamide-Quinazoline based hybrid analogs as potential pancreatic lipase inhibitors for Obesity treatment
Computational design, synthesis and screening of non-hydroxamate lipophilic DXR inhibitors as potential antibacterial/antimalarial/anti-TB agents
Design & Synthesis of Mycobacterium UDG Inhibitors
Design and synthesis of inhibitors of mycobactgerium tuberculosis sigma factor RNAP protein-protein interaction as potential antimycobacterial agents”
Role of Endocrine Disrupting chemicals (ECDs) in Maternal and Child Health
Exploring the Mechanisms(s) of gut microbiota link to parkinson disease pathology and its reversal based on fibroblast growth factor 21 gene delivery through lentivirus system
Sertraline intervention for enhancing anti-TB therapeutic regimen (SINERG)
Development of a complete skin substitute by autologous cell grafting using an in-situ forming bioactive scaffold for burn wound healing